The role of empirical albendazole treatment in idiopathic hypereosinophilia - a case series

Eleonora Vaisben, Ronen Brand, Anas Kadakh, Faris Nassar, Eleonora Vaisben, Ronen Brand, Anas Kadakh, Faris Nassar

Abstract

Hypereosinophilia is usually defined as a blood eosinophil count >1500/μL. A broad variety of conditions are associated with hypereosinophilia. The present report describes three cases of hypereosinophilia, in which a thorough history, physical examination, laboratory and imaging investigations were unable to detect any abnormalities. Albendazole was empirically administered in all three cases, with complete normalization of eosinophil counts thereafter. Empirical treatment with albendazole for patients presenting with hypereosinophilia should be strongly considered.

Keywords: Albendazole; Hypereosinophilia; Hypereosinophilic syndrome.

References

    1. Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010;126:39–44.
    1. Ang AL, Wong RX, Zhuang QY, Linn YC. Natural history of severe eosinophilia with uncertain aetiology and proposals on a practical approach to its management. Intern Med J. 2012;42:928–33.
    1. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010;12:45–9.
    1. Klion A. Hypereosinophilic syndrome: Current approach to diagnosis and treatment. Annu Rev Med. 2009;60:293–306.
    1. Insiripong S, Siriyakorn N. Treatment of eosinophilia with albendazole. Southeast Asian J Trop Med Public Health. 2008;39:517–20.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi